Cotard’s syndrome is a rare condition in which a person genuinely believes they are dead, do not exist, or have lost their organs, blood, or soul. First described by the French neurologist Jules Cotard in the early 1880s, it is sometimes called “walking corpse syndrome.” It affects fewer than 1% of psychiatric inpatients and is not a standalone diagnosis in current psychiatric manuals but rather a set of delusions that emerges alongside other conditions like severe depression, schizophrenia, or neurological disease.
What It Feels Like
The hallmark of Cotard’s syndrome is what clinicians call nihilistic delusions: a fixed, unshakable belief that something fundamental about your body or existence has been negated. In milder forms, a person might insist that a specific organ has stopped working or disappeared. In more severe presentations, the belief extends to total nonexistence, the conviction that one is literally dead or that the world around them has ceased to be real.
Case reports illustrate how vivid and specific these beliefs can be. One patient described in the psychiatric literature insisted “my heart does not beat,” “my stomach is being destroyed,” “my palate disappeared,” and “I have no blood.” Another refused to eat, reasoning that a dead person has no need for food. Some people develop the paradoxical belief that they are immortal, unable to die because they are already dead.
A review of reported cases found that the most common features are depression (89%), nihilistic delusions about the body (86%), denial of one’s own existence (69%), anxiety (65%), feelings of guilt (63%), and delusions of immortality (55%). Pain insensitivity has also been documented, where a person stops registering physical discomfort in a way that aligns with their belief that their body is no longer alive.
How the Syndrome Progresses
Cotard’s syndrome tends to unfold in three stages. The first, called the germination stage, involves vague feelings of depression and a growing sense that something is physically wrong. This may resemble ordinary health anxiety or depersonalization, the unsettling feeling of being detached from your own body.
The second stage, blooming, is when full nihilistic delusions take hold. This is the period of peak severity, where the person firmly believes they are dead, their organs are missing, or they do not exist. The third stage is the chronic phase. In some people, this takes a primarily depressive form, while in others the delusions persist with a more paranoid character. The chronic stage can stabilize into long-term delusional thinking that may not immediately suggest an underlying mood disorder to those around the person.
What Happens in the Brain
Cotard’s syndrome is linked to dysfunction in specific brain regions. Research points to abnormalities in the non-dominant hemisphere’s frontal, temporal, and parietal lobes, with particular involvement of the fusiform gyrus. This is the area of the brain responsible for recognizing faces, including your own. When it malfunctions alongside the emotional processing centers, the result can be a profound disconnection between what you see (your own body, your own reflection) and any sense of familiarity or ownership over it.
This helps explain why Cotard’s syndrome shares features with depersonalization and derealization, where the world or the self feels unreal. In Cotard’s, this disconnection is so extreme that the brain constructs a delusional explanation: “I must be dead.”
Conditions That Trigger It
Cotard’s syndrome almost always appears in the context of another illness. The most common trigger is severe psychotic depression, particularly what older literature calls “anxious melancholia,” a combination of deep depression, intense anxiety, and feelings of guilt or damnation. An analysis of 100 patients identified three subgroups: one with clear psychotic depression, a second with a purer delusional form more closely related to delusional disorders, and a third mixed group featuring anxiety, depression, and auditory hallucinations.
Neurological conditions can also produce Cotard’s syndrome. Documented triggers include Parkinson’s disease, brain tumors, traumatic brain injury, multiple sclerosis, viral encephalitis, and even migraine in rare cases. In one large neuropsychiatry sample, about 0.11% of neurological patients developed the syndrome. Among psychiatric inpatients, the rate was somewhat higher, around 0.6% to 0.9% depending on the study. It has been reported in patients as young as their late twenties and in older adults, with an estimated occurrence in about 3% of older adults who have severe depression.
Despite Cotard’s syndrome being well described in schizophrenia, it appears to be genuinely uncommon in that population. A review of 150 schizophrenia patients found none with clear nihilistic delusions, and the total number of co-occurring cases reported in the entire medical literature is remarkably small.
How It Is Diagnosed
There is no single blood test or brain scan that confirms Cotard’s syndrome. It is identified through clinical interview, when a patient expresses nihilistic delusions about their body or existence. Because it is not listed as a standalone diagnosis in the major psychiatric classification systems, it is typically documented as a feature of the underlying condition, such as major depression with psychotic features.
Clinicians can assess the severity of Cotard-type delusions using standardized tools like the Questionnaire for Psychotic Experiences, which rates delusions on a six-point scale measuring conviction, preoccupation, distress, and impact on daily functioning. Other common scales for tracking delusion severity include the Psychotic Symptom Rating Scales and the Positive and Negative Syndrome Scale.
Treatment and Recovery
Because Cotard’s syndrome is driven by an underlying condition, treatment targets that root cause. When severe depression is the trigger, the first step is usually a combination of antidepressant and antipsychotic medication. In some cases, this is enough to resolve the nihilistic delusions along with the depressive episode.
When medication alone does not work, electroconvulsive therapy (ECT) has proven highly effective, particularly for depression-driven Cotard’s syndrome. In one well-documented case, a patient whose delusions did not respond to antidepressants or antipsychotics experienced complete resolution after a course of twelve ECT sessions. She returned to eating normally, sleeping well, attending to personal hygiene, and carrying out daily activities with no remaining nihilistic beliefs. Maintenance ECT sessions, spaced at increasing intervals, kept her in full remission.
Recovery timelines vary depending on the underlying condition and how quickly treatment begins. For neurological causes, treating the brain pathology itself, whether that means addressing an infection, managing a tumor, or stabilizing a degenerative condition, is essential. The delusions typically do not resolve on their own without addressing what is driving them.